[Psychiatric complications in the treatment of obesity using fenfluramine]. 1988

J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011605 Psychoses, Substance-Induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. Psychoses, Drug,Psychoses, Toxic,Substance-Induced Psychoses,Toxic Psychoses,Drug Psychoses,Psychoses, Substance Induced,Substance Induced Psychoses
D005260 Female Females
D005277 Fenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. Fintepla,Fenfluramine Hydrochloride,Fenfluramine Hydrochloride, (+-)-Isomer,Fenfluramine Hydrochloride, R-Isomer,Fenfluramine, (+-)-Isomer,Fenfluramine, R-Isomer,Isomeride,Pondimin,Fenfluramine Hydrochloride, R Isomer,Fenfluramine, R Isomer,Hydrochloride, Fenfluramine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
November 1968, The Medical journal of Australia,
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
March 1973, La Vie medicale au Canada francais,
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
December 1966, The British journal of clinical practice,
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
March 1973, Lancet (London, England),
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
March 1973, Lancet (London, England),
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
January 1975, Wiener medizinische Wochenschrift (1946),
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
August 1973, European journal of clinical pharmacology,
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
January 1972, Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry,
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
September 1973, Ugeskrift for laeger,
J L Klompenhouwer, and B H Stricker, and A J van Tilburg, and P Moleman, and L Pepplinkhuizen
September 1966, British medical journal,
Copied contents to your clipboard!